Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics.

Johannes A Kroes,Kim de Jong,Simone Hashimoto,Sander W Zielhuis,Eric N van Roon,Jacob K Sont,Anneke Ten Brinke

ERJ open research（2023）

引用 0|浏览7

暂无评分

摘要

In addition to baseline characteristics, treatment outcomes at 3 months contribute to the prediction of benralizumab response at 1 year in patients with severe eosinophilic asthma. Prediction tools as proposed in this study may help physicians optimise the use of costly biologics.

查看译文

关键词

benralizumab,clinical response,clinical outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要